Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 463

1.

Using Spontaneous Eye-blink Rates to Predict the Motor Status of Patients with Parkinson's Disease.

Iwaki H, Sogo H, Morita H, Nishikawa N, Ando R, Miyaue N, Tada S, Yabe H, Nagai M, Nomoto M.

Intern Med. 2019;58(10):1417-1421. doi: 10.2169/internalmedicine.1960-18. Epub 2019 May 15.

2.

Transcriptome analysis and identification of a transcriptional regulatory network in the response to H2O2.

Hieno A, Naznin HA, Inaba-Hasegawa K, Yokogawa T, Hayami N, Nomoto M, Tada Y, Yokogawa T, Higuchi-Takeuchi M, Hanada K, Matsui M, Ikeda Y, Hojo Y, Hirayama T, Kusunoki K, Koyama H, Mitsuda N, Yamamoto YY.

Plant Physiol. 2019 May 7. pii: pp.01426.2018. doi: 10.1104/pp.18.01426. [Epub ahead of print]

3.

Long-Term Selegiline Monotherapy for the Treatment of Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N.

Clin Neuropharmacol. 2019 Apr 30. doi: 10.1097/WNF.0000000000000343. [Epub ahead of print]

PMID:
31045589
4.

A case of ADEM-like presentation with anti-MOG antibody following tumefactive demyelinating lesion.

Miyaue N, Yamanishi Y, Tada S, Ando R, Yabe H, Nagai M, Nomoto M.

Mult Scler Relat Disord. 2019 Mar 26;31:62-64. doi: 10.1016/j.msard.2019.03.018. [Epub ahead of print]

PMID:
30933712
5.

IFPA meeting 2018 workshop report II: Abnormally invasive placenta; inflammation and infection; preeclampsia; gestational trophoblastic disease and drug delivery.

Albrecht C, Chamley L, Charnock-Jones DS, Collins S, Fujiwara H, Golos T, Grayo S, Hannan N, Harris L, Ichizuka K, Illsley NP, Iwashita M, Kallol S, Al-Khan A, Lash G, Nagamatsu T, Nakashima A, Niimi K, Nomoto M, Redman C, Saito S, Tanimura K, Tomi M, Usui H, Vatish M, Wolfe B, Yamamoto E, O'Tierney-Ginn P.

Placenta. 2019 Feb 12. pii: S0143-4004(18)31200-1. doi: 10.1016/j.placenta.2019.02.006. [Epub ahead of print] Review.

PMID:
30773233
6.

Repetitive brainstem lesions in mitochondrial DNA 11778G>A mutation of Leber hereditary optic neuropathy.

Miyaue N, Yamanishi Y, Tada S, Ando R, Yabe H, Nagai M, Nomoto M.

eNeurologicalSci. 2019 Jan 11;14:74-76. doi: 10.1016/j.ensci.2019.01.002. eCollection 2019 Mar.

7.

A comparative analysis of hepatic pathological phenotypes in C57BL/6J and C57BL/6N mouse strains in non-alcoholic steatohepatitis models.

Kawashita E, Ishihara K, Nomoto M, Taniguchi M, Akiba S.

Sci Rep. 2019 Jan 18;9(1):204. doi: 10.1038/s41598-018-36862-7.

8.

Artificial association of memory events by optogenetic stimulation of hippocampal CA3 cell ensembles.

Oishi N, Nomoto M, Ohkawa N, Saitoh Y, Sano Y, Tsujimura S, Nishizono H, Matsuo M, Muramatsu SI, Inokuchi K.

Mol Brain. 2019 Jan 8;12(1):2. doi: 10.1186/s13041-018-0424-1.

9.

Proteasome-associated HECT-type ubiquitin ligase activity is required for plant immunity.

Furniss JJ, Grey H, Wang Z, Nomoto M, Jackson L, Tada Y, Spoel SH.

PLoS Pathog. 2018 Nov 20;14(11):e1007447. doi: 10.1371/journal.ppat.1007447. eCollection 2018 Nov.

10.

Behavioral tests predicting striatal dopamine level in a rat hemi-Parkinson's disease model.

Miyanishi K, Choudhury ME, Watanabe M, Kubo M, Nomoto M, Yano H, Tanaka J.

Neurochem Int. 2019 Jan;122:38-46. doi: 10.1016/j.neuint.2018.11.005. Epub 2018 Nov 9.

PMID:
30419255
11.

Pharmacokinetics and safety/efficacy of levodopa pro-drug ONO-2160/carbidopa for Parkinson's disease.

Nomoto M, Nagai M, Nishikawa N, Ando R, Kagamiishi Y, Yano K, Saito S, Takeda A.

eNeurologicalSci. 2018 Sep 17;13:8-13. doi: 10.1016/j.ensci.2018.09.003. eCollection 2018 Dec.

12.

Pharmacokinetic disposition of topical phosphodiesterase-4 inhibitor E6005 in patients with atopic dermatitis.

Kitahara Y, Hojo S, Nomoto M, Onozuka D, Furue M, Hagihara A.

J Dermatolog Treat. 2018 Nov 19:1-5. doi: 10.1080/09546634.2018.1530439. [Epub ahead of print]

PMID:
30265585
13.

Prevention of anastomotic leak using an advanced pectoral flap in total pharyngolaryngectomy and free jejunal reconstruction for hypopharyngeal or laryngeal carcinoma.

Kondo T, Tsukahara K, Yoshizawa N, Okamoto I, Motohashi R, Nomoto M, Katsube Y, Yatomi M, Iwasawa T, Hanyu K, Ogawa Y.

Acta Otolaryngol. 2018 Oct;138(10):951-955. doi: 10.1080/00016489.2018.1492152. Epub 2018 Sep 27.

PMID:
30261803
14.

Enantioselective Bromolactonization of Trisubstituted Olefinic Acids Catalyzed by Chiral Pyridyl Phosphoramides.

Nishikawa Y, Hamamoto Y, Satoh R, Akada N, Kajita S, Nomoto M, Miyata M, Nakamura M, Matsubara C, Hara O.

Chemistry. 2018 Dec 17;24(71):18880-18885. doi: 10.1002/chem.201804630. Epub 2018 Nov 26.

PMID:
30230634
15.

Cell-Free Protein Synthesis of Plant Transcription Factors.

Nomoto M, Tada Y.

Methods Mol Biol. 2018;1830:337-349. doi: 10.1007/978-1-4939-8657-6_20.

PMID:
30043380
16.

[Generation and Inception of Memories by Manipulating Neuronal Activity].

Nomoto M, Inokuchi K.

Brain Nerve. 2018 Jul;70(7):699-711. doi: 10.11477/mf.1416201071. Japanese.

PMID:
29997266
17.

Falling After Starting Running in a Case of Myoclonus Epilepsy Associated with Ragged-red Fibers with a 8344A>G mtDNA Mutation.

Miyaue N, Yamanishi Y, Tada S, Ando R, Nagai M, Nomoto M.

Intern Med. 2018 Dec 1;57(23):3439-3443. doi: 10.2169/internalmedicine.1210-18. Epub 2018 Jul 6.

18.
19.

Label-free and spectral-analysis-free detection of neuropsychiatric disease biomarkers using an ion-sensitive GaInAsP nanolaser biosensor.

Watanabe K, Nomoto M, Nakamura F, Hachuda S, Sakata A, Watanabe T, Goshima Y, Baba T.

Biosens Bioelectron. 2018 Oct 15;117:161-167. doi: 10.1016/j.bios.2018.05.059. Epub 2018 Jun 2.

PMID:
29894853
20.

MYB30 links ROS signaling, root cell elongation, and plant immune responses.

Mabuchi K, Maki H, Itaya T, Suzuki T, Nomoto M, Sakaoka S, Morikami A, Higashiyama T, Tada Y, Busch W, Tsukagoshi H.

Proc Natl Acad Sci U S A. 2018 May 15;115(20):E4710-E4719. doi: 10.1073/pnas.1804233115. Epub 2018 Apr 30.

21.

Modafinil alleviates levodopa-induced excessive nighttime sleepiness and restores monoaminergic systems in a nocturnal animal model of Parkinson's disease.

Ando R, Choudhury ME, Yamanishi Y, Kyaw WT, Kubo M, Kannou M, Nishikawa N, Tanaka J, Nomoto M, Nagai M.

J Pharmacol Sci. 2018 Apr;136(4):266-271. doi: 10.1016/j.jphs.2018.03.005. Epub 2018 Mar 31.

22.

Behavioral, cellular, and synaptic tagging frameworks.

Nomoto M, Inokuchi K.

Neurobiol Learn Mem. 2018 Sep;153(Pt A):13-20. doi: 10.1016/j.nlm.2018.03.010. Epub 2018 Mar 10.

PMID:
29535042
23.

The Clinical Findings Useful for Driving Safety Advice for Parkinson's Disease Patients.

Ando R, Iwaki H, Tsujii T, Nagai M, Nishikawa N, Yabe H, Aiba I, Hasegawa K, Tsuboi Y, Aoki M, Nakashima K, Nomoto M; Parkinson's Disease Safe Driving Study Group of Japan.

Intern Med. 2018 Jul 15;57(14):1977-1982. doi: 10.2169/internalmedicine.9653-17. Epub 2018 Feb 28.

24.

Arabidopsis Zinc-Finger-Like Protein ASYMMETRIC LEAVES2 (AS2) and Two Nucleolar Proteins Maintain Gene Body DNA Methylation in the Leaf Polarity Gene ETTIN (ARF3).

Vial-Pradel S, Keta S, Nomoto M, Luo L, Takahashi H, Suzuki M, Yokoyama Y, Sasabe M, Kojima S, Tada Y, Machida Y, Machida C.

Plant Cell Physiol. 2018 Jul 1;59(7):1385-1397. doi: 10.1093/pcp/pcy031.

PMID:
29415182
25.

Chemical hijacking of auxin signaling with an engineered auxin-TIR1 pair.

Uchida N, Takahashi K, Iwasaki R, Yamada R, Yoshimura M, Endo TA, Kimura S, Zhang H, Nomoto M, Tada Y, Kinoshita T, Itami K, Hagihara S, Torii KU.

Nat Chem Biol. 2018 Mar;14(3):299-305. doi: 10.1038/nchembio.2555. Epub 2018 Jan 22.

26.

Pharmacokinetic/pharmacodynamic drug-drug interactions of avatrombopag when coadministered with dual or selective CYP2C9 and CYP3A interacting drugs.

Nomoto M, Zamora CA, Schuck E, Boyd P, Chang MK, Aluri J, Siu YA, Lai WG, Yasuda S, Ferry J, Rege B.

Br J Clin Pharmacol. 2018 May;84(5):952-960. doi: 10.1111/bcp.13517. Epub 2018 Feb 20.

28.

Management of neuropathic pain.

Nishikawa N, Nomoto M.

J Gen Fam Med. 2017 Apr 12;18(2):56-60. doi: 10.1002/jgf2.5. eCollection 2017 Apr. Review.

29.

One year safety and efficacy of inosine to increase the serum urate level for patients with Parkinson's disease in Japan.

Iwaki H, Ando R, Miyaue N, Tada S, Tsujii T, Yabe H, Nishikawa N, Nagai M, Nomoto M.

J Neurol Sci. 2017 Dec 15;383:75-78. doi: 10.1016/j.jns.2017.10.030. Epub 2017 Oct 24.

PMID:
29246629
30.
31.
32.

In Vitro Human Onychopharmacokinetic and Pharmacodynamic Analyses of ME1111, a New Topical Agent for Onychomycosis.

Kubota-Ishida N, Takei-Masuda N, Kaneda K, Nagira Y, Chikada T, Nomoto M, Tabata Y, Takahata S, Maebashi K, Hui X, Maibach HI.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e00779-17. doi: 10.1128/AAC.00779-17. Print 2018 Jan.

33.

A Randomized Double-Blind Placebo-Controlled Phase III Trial of Selegiline Monotherapy for Early Parkinson Disease.

Mizuno Y, Hattori N, Kondo T, Nomoto M, Origasa H, Takahashi R, Yamamoto M, Yanagisawa N.

Clin Neuropharmacol. 2017 Sep/Oct;40(5):201-207. doi: 10.1097/WNF.0000000000000239.

34.

DAT SPECT may have diagnostic value in prodromal SCA2 patients with parkinsonism.

Miyaue N, Tada S, Ando R, Iwaki H, Yabe H, Nishikawa N, Nagai M, Takashima H, Nomoto M.

Parkinsonism Relat Disord. 2017 Nov;44:137-141. doi: 10.1016/j.parkreldis.2017.08.012. Epub 2017 Aug 14.

PMID:
28844804
35.

Microglia may compensate for dopaminergic neuron loss in experimental Parkinsonism through selective elimination of glutamatergic synapses from the subthalamic nucleus.

Aono H, Choudhury ME, Higaki H, Miyanishi K, Kigami Y, Fujita K, Akiyama JI, Takahashi H, Yano H, Kubo M, Nishikawa N, Nomoto M, Tanaka J.

Glia. 2017 Nov;65(11):1833-1847. doi: 10.1002/glia.23199. Epub 2017 Aug 24.

PMID:
28836295
36.

Cascade stomach associated with delayed-on or no-on phenomenon in a patient with Parkinson's disease.

Miyaue N, Tada S, Ando R, Yabe H, Nishikawa N, Nagai M, Nomoto M.

Mov Disord. 2017 Oct;32(10):1492-1493. doi: 10.1002/mds.27109. Epub 2017 Aug 7. No abstract available.

PMID:
28782858
37.

Immunohistochemical expression profiles of mucin antigens in salivary gland mucoepidermoid carcinoma: MUC4- and MUC6-negative expression predicts a shortened survival in the early postoperative phase.

Honjo K, Hiraki T, Higashi M, Noguchi H, Nomoto M, Yoshimura T, Batra SK, Yonezawa S, Semba I, Nakamura N, Tanimoto A, Yamada S.

Histol Histopathol. 2018 Feb;33(2):201-213. doi: 10.14670/HH-11-913. Epub 2017 Jun 26.

PMID:
28649694
38.

Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects.

Nomoto M, Pastino G, Rege B, Aluri J, Ferry J, Han D.

Clin Pharmacol Drug Dev. 2018 Feb;7(2):188-195. doi: 10.1002/cpdd.349. Epub 2017 Mar 24.

PMID:
28339166
39.

Clinical manifestations of nonmotor symptoms in 1021 Japanese Parkinson's disease patients from 35 medical centers.

Maeda T, Shimo Y, Chiu SW, Yamaguchi T, Kashihara K, Tsuboi Y, Nomoto M, Hattori N, Watanabe H, Saiki H; J-FIRST group.

Parkinsonism Relat Disord. 2017 May;38:54-60. doi: 10.1016/j.parkreldis.2017.02.024. Epub 2017 Feb 21.

40.

Prediction of bipartite transcriptional regulatory elements using transcriptome data of Arabidopsis.

Yamamoto YY, Ichida H, Hieno A, Obata D, Tokizawa M, Nomoto M, Tada Y, Kusunoki K, Koyama H, Hayami N.

DNA Res. 2017 Jun 1;24(3):271-278. doi: 10.1093/dnares/dsw065.

41.

Overlapping memory trace indispensable for linking, but not recalling, individual memories.

Yokose J, Okubo-Suzuki R, Nomoto M, Ohkawa N, Nishizono H, Suzuki A, Matsuo M, Tsujimura S, Takahashi Y, Nagase M, Watabe AM, Sasahara M, Kato F, Inokuchi K.

Science. 2017 Jan 27;355(6323):398-403. doi: 10.1126/science.aal2690.

PMID:
28126819
42.

HSP90 Stabilizes Auxin-Responsive Phenotypes by Masking a Mutation in the Auxin Receptor TIR1.

Watanabe E, Mano S, Nomoto M, Tada Y, Hara-Nishimura I, Nishimura M, Yamada K.

Plant Cell Physiol. 2016 Nov;57(11):2245-2254. Epub 2016 Oct 22.

PMID:
27816945
43.

The Arabidopsis CERK1-associated kinase PBL27 connects chitin perception to MAPK activation.

Yamada K, Yamaguchi K, Shirakawa T, Nakagami H, Mine A, Ishikawa K, Fujiwara M, Narusaka M, Narusaka Y, Ichimura K, Kobayashi Y, Matsui H, Nomura Y, Nomoto M, Tada Y, Fukao Y, Fukamizo T, Tsuda K, Shirasu K, Shibuya N, Kawasaki T.

EMBO J. 2016 Nov 15;35(22):2468-2483. Epub 2016 Sep 27.

44.

[Safe and Effective Analgesia with Bilateral Continuous TAP Block for a Patient with Marfan Syndrome after Open Abdominal Aortic Aneurysm Repair].

Katakura Y, Sakurai A, Endo M, Hamada T, Nomoto M, Yamada H, Takeda K.

Masui. 2016 Jun;65(6):621-3. Japanese.

PMID:
27483660
45.

Cellular tagging as a neural network mechanism for behavioural tagging.

Nomoto M, Ohkawa N, Nishizono H, Yokose J, Suzuki A, Matsuo M, Tsujimura S, Takahashi Y, Nagase M, Watabe AM, Kato F, Inokuchi K.

Nat Commun. 2016 Aug 1;7:12319. doi: 10.1038/ncomms12319.

46.

Loss of function at RAE2, a previously unidentified EPFL, is required for awnlessness in cultivated Asian rice.

Bessho-Uehara K, Wang DR, Furuta T, Minami A, Nagai K, Gamuyao R, Asano K, Angeles-Shim RB, Shimizu Y, Ayano M, Komeda N, Doi K, Miura K, Toda Y, Kinoshita T, Okuda S, Higashiyama T, Nomoto M, Tada Y, Shinohara H, Matsubayashi Y, Greenberg A, Wu J, Yasui H, Yoshimura A, Mori H, McCouch SR, Ashikari M.

Proc Natl Acad Sci U S A. 2016 Aug 9;113(32):8969-74. doi: 10.1073/pnas.1604849113. Epub 2016 Jul 27.

47.

Japanese version of the ALS-FTD-Questionnaire (ALS-FTD-Q-J).

Watanabe Y, Beeldman E, Raaphorst J, Izumi Y, Yoshino H, Masuda M, Atsuta N, Ito S, Adachi T, Adachi Y, Yokota O, Oda M, Hanashima R, Ogino M, Ichikawa H, Hasegawa K, Kimura H, Shimizu T, Aiba I, Yabe H, Kanba M, Kusumi K, Aoki T, Hiroe Y, Watanabe H, Nishiyama K, Nomoto M, Sobue G, Nakashima K; ALS-FTD-Q-J Research Group.

J Neurol Sci. 2016 Aug 15;367:51-5. doi: 10.1016/j.jns.2016.05.036. Epub 2016 May 18.

PMID:
27423564
48.
49.

Phytochrome Signaling Is Mediated by PHYTOCHROME INTERACTING FACTOR in the Liverwort Marchantia polymorpha.

Inoue K, Nishihama R, Kataoka H, Hosaka M, Manabe R, Nomoto M, Tada Y, Ishizaki K, Kohchi T.

Plant Cell. 2016 Jun;28(6):1406-21. doi: 10.1105/tpc.15.01063. Epub 2016 Jun 1.

50.

Efficacy of a novel phosphodiesterase inhibitor, E6005, in patients with atopic dermatitis: An investigator-blinded, vehicle-controlled study.

Ohba F, Matsuki S, Imayama S, Matsuguma K, Hojo S, Nomoto M, Akama H.

J Dermatolog Treat. 2016 Oct;27(5):467-72. doi: 10.3109/09546634.2016.1157257. Epub 2016 Apr 14.

PMID:
27080209

Supplemental Content

Loading ...
Support Center